Medpace logo

Medpace

North America, Ohio, United States, Cincinnati

Description

Medpace, Inc., a clinical research organization, provides clinical development services for pharmaceutical and biotechnology

Investor Profile

Medpace has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (67%)
  • Series B (33%)

Country Focus

  • United States (67%)
  • The Netherlands (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Therapeutics
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medpace frequently co-invest with?

LSP BioVentures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Helix Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
JVC Investment Partners
North America, Illinois, United States, Northbrook
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
AB
North America, Delaware, United States, Wilmington
Co-Investments: 1
Kaiser Permanente
North America, California, United States, Oakland
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
GL Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Medpace often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Medpace?

New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Series AJan 14, 2021
Amount Raised: $194,412,819
Coherus Biosciences

Redwood City, California, United States

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series BJan 1, 2012
Amount Raised: $61,500,000
Coherus Biosciences

Redwood City, California, United States

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AMar 1, 2011
Amount Raised: $1,500,000